[HTML][HTML] Global prevalence and molecular epidemiology of mcr-mediated colistin resistance in Escherichia coli clinical isolates: A systematic review

M Dadashi, F Sameni, N Bostanshirin… - Journal of global …, 2022 - Elsevier
Objectives The continuing rise in infections caused by multidrug-resistant (MDR) bacteria is
one of the most serious public-health issues in society today. Colistin is a last-resort …

Colistin-resistance gene mcr in clinical carbapenem-resistant Enterobacteriaceae strains in China, 2014–2019

H Huang, N Dong, L Shu, J Lu, Q Sun… - Emerging microbes & …, 2020 - Taylor & Francis
To investigate whether introduction of colistin into the clinical settings selected colistin-
resistant CRE, we performed molecular epidemiological study of 1868 CRE strains collected …

Genomic Insights into Global blaCTX-M-55-Positive Escherichia coli Epidemiology and Transmission Characteristics

JT Yang, LJ Zhang, Y Lu, RM Zhang… - Microbiology …, 2023 - Am Soc Microbiol
In recent years, bla CTX-M-55-positive Escherichia coli has been widely reported in multiple
locations with an increasing trend in prevalence, yet few studies have comprehensively …

International clones of extended‐spectrum β‐lactamase (CTX‐M)‐producing Escherichia coli in peri‐urban wild animals, Brazil

MPN de Carvalho, MR Fernandes… - Transboundary and …, 2020 - Wiley Online Library
CTX‐M‐type extended‐spectrum β‐lactamase (ESBL)‐producing Escherichia coli clones
have been increasingly reported worldwide. In this regard, although discussions of …

In vitro activity of a novel siderophore-cephalosporin, GT-1 and serine-type β-lactamase inhibitor, GT-055, against Escherichia coli, Klebsiella pneumoniae and …

LP Nguyen, NA Pinto, TN Vu, H Lee, YL Cho, JH Byun… - Antibiotics, 2020 - mdpi.com
This study investigates GT-1 (also known as LCB10-0200), a novel-siderophore
cephalosporin, inhibited multidrug-resistant (MDR) Gram-negative pathogen, via a Trojan …

Polyclonal dissemination of NDM-1-and NDM-9-producing Escherichia coli and Klebsiella pneumoniae in French Polynesia

S Oueslati, C Emeraud, V Grosperrin… - Antimicrobial agents …, 2021 - Am Soc Microbiol
The whole-genome sequencing analysis revealed a polyclonal dissemination of NDM-1 and
NDM-9 variants in Escherichia coli (n= 20) and Klebsiella pneumoniae (n= 2) in Tahiti since …

In vitro activity of a novel siderophore-cephalosporin LCB10-0200 (GT-1), and LCB10-0200/avibactam, against carbapenem-resistant Escherichia coli, Klebsiella …

LP Nguyen, CS Park, NA Pinto, H Lee, HS Seo, TN Vu… - Pharmaceuticals, 2021 - mdpi.com
The siderophore–antibiotic conjugate LCB10-0200 (aka GT-1) has been developed to
combat multidrug-resistant Gram-negative bacteria. In this study, the in vitro activity of …

分析由寵物所分離出來帶有extended-spectrum-β-lactamase, pAmpC 或MCR-1 基因的大腸桿菌

劉芳伶 - 2021 - tdr.lib.ntu.edu.tw
" 近年來, 細菌抗藥性, 是全球所關注的議題, 其中大腸桿菌更是被列為抗第三代頭孢菌素的重要
監測對象之一. 第三代頭孢菌素是獸醫及人醫臨床治療上常使用的抗菌劑之一 …

[PDF][PDF] In Vitro Activity of a Novel Siderophore-Cephalosporin, GT-1 and Serine-Type β-Lactamase Inhibitor, GT-055, against Escherichia coli, Klebsiella …

YL Cho, JH Byun, R D'Souza, D Yong - pdfs.semanticscholar.org
This study investigates GT-1 (also known as LCB10-0200), a novel-siderophore
cephalosporin, inhibited multidrug-resistant (MDR) Gram-negative pathogen, via a Trojan …

[引用][C] Panel strain bank construction and characterization of gene network of β-lactam resistance in Escherichia coli clinical isolates, focusing on carbapenems and …

PN Le - 2021 - 연세대학교